These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 25450338)

  • 1. Systems biology of ion channels and transporters in tumor angiogenesis: An omics view.
    Munaron L
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2647-56. PubMed ID: 25450338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ion channels and transporters in metastasis.
    Stock C; Schwab A
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2638-46. PubMed ID: 25445667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key roles of aquaporins in tumor biology.
    Papadopoulos MC; Saadoun S
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2576-83. PubMed ID: 25204262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional properties of ion channels and transporters in tumour vascularization.
    Fiorio Pla A; Munaron L
    Philos Trans R Soc Lond B Biol Sci; 2014 Mar; 369(1638):20130103. PubMed ID: 24493751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane channels and transporters in cancers.
    Hervé JC
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2473-6. PubMed ID: 26100062
    [No Abstract]   [Full Text] [Related]  

  • 6. Ovarian cancer: Ion channel and aquaporin expression as novel targets of clinical potential.
    Frede J; Fraser SP; Oskay-Özcelik G; Hong Y; Ioana Braicu E; Sehouli J; Gabra H; Djamgoz MB
    Eur J Cancer; 2013 Jul; 49(10):2331-44. PubMed ID: 23683551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ion channels in the regulation of apoptosis.
    Kondratskyi A; Kondratska K; Skryma R; Prevarskaya N
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2532-46. PubMed ID: 25450339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of potassium channels in the progression of cancer to a more malignant phenotype.
    Comes N; Serrano-Albarrás A; Capera J; Serrano-Novillo C; Condom E; Ramón Y Cajal S; Ferreres JC; Felipe A
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2477-92. PubMed ID: 25517985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of ion channels and transporters in carcinoma angiogenesis and metastasis.
    Martial S
    Am J Physiol Cell Physiol; 2016 May; 310(9):C710-27. PubMed ID: 26791487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial cell integrins and COX-2: mediators and therapeutic targets of tumor angiogenesis.
    Rüegg C; Dormond O; Mariotti A
    Biochim Biophys Acta; 2004 Mar; 1654(1):51-67. PubMed ID: 14984767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vesicular trafficking mechanisms in endothelial cells as modulators of the tumor vasculature and targets of antiangiogenic therapies.
    Maes H; Olmeda D; Soengas MS; Agostinis P
    FEBS J; 2016 Jan; 283(1):25-38. PubMed ID: 26443003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ion channel expression as promising cancer biomarker.
    Lastraioli E; Iorio J; Arcangeli A
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2685-702. PubMed ID: 25542783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chloride channels in cancer: Focus on chloride intracellular channel 1 and 4 (CLIC1 AND CLIC4) proteins in tumor development and as novel therapeutic targets.
    Peretti M; Angelini M; Savalli N; Florio T; Yuspa SH; Mazzanti M
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2523-31. PubMed ID: 25546839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activin A suppresses neuroblastoma xenograft tumor growth via antimitotic and antiangiogenic mechanisms.
    Panopoulou E; Murphy C; Rasmussen H; Bagli E; Rofstad EK; Fotsis T
    Cancer Res; 2005 Mar; 65(5):1877-86. PubMed ID: 15753386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole] inhibits endothelial cell functions induced by angiogenic factors in vitro and angiogenesis in vivo models.
    Pan SL; Guh JH; Peng CY; Wang SW; Chang YL; Cheng FC; Chang JH; Kuo SC; Lee FY; Teng CM
    J Pharmacol Exp Ther; 2005 Jul; 314(1):35-42. PubMed ID: 15784655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology.
    Tate CM; Mc Entire J; Pallini R; Vakana E; Wyss L; Blosser W; Ricci-Vitiani L; D'Alessandris QG; Morgante L; Giannetti S; Larocca LM; Todaro M; Benfante A; Colorito ML; Stassi G; De Maria R; Rowlinson S; Stancato L
    PLoS One; 2015; 10(4):e0125697. PubMed ID: 25919028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aquaporins in tumor growth and angiogenesis.
    Nico B; Ribatti D
    Cancer Lett; 2010 Aug; 294(2):135-8. PubMed ID: 20199845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A/VEGFR2 pathway.
    Lorenzon E; Colladel R; Andreuzzi E; Marastoni S; Todaro F; Schiappacassi M; Ligresti G; Colombatti A; Mongiat M
    Oncogene; 2012 Jun; 31(26):3136-47. PubMed ID: 22020326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SKLB1002, a novel potent inhibitor of VEGF receptor 2 signaling, inhibits angiogenesis and tumor growth in vivo.
    Zhang S; Cao Z; Tian H; Shen G; Ma Y; Xie H; Liu Y; Zhao C; Deng S; Yang Y; Zheng R; Li W; Zhang N; Liu S; Wang W; Dai L; Shi S; Cheng L; Pan Y; Feng S; Zhao X; Deng H; Yang S; Wei Y
    Clin Cancer Res; 2011 Jul; 17(13):4439-50. PubMed ID: 21622720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of ion channels and transporters in cell migration.
    Schwab A; Fabian A; Hanley PJ; Stock C
    Physiol Rev; 2012 Oct; 92(4):1865-913. PubMed ID: 23073633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.